APA (7th ed.) Citation

Cummings, J. L., Atri, A., Feldman, H. H., Hansson, O., Sano, M., Knop, F. K., . . . Scheltens, P. evoke and evoke+: Design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. BMC.

Chicago Style (17th ed.) Citation

Cummings, Jeffrey L., Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, and Philip Scheltens. Evoke and Evoke+: Design of Two Large-scale, Double-blind, Placebo-controlled, Phase 3 Studies Evaluating Efficacy, Safety, and Tolerability of Semaglutide in Early-stage Symptomatic Alzheimer’s Disease. BMC.

MLA (9th ed.) Citation

Cummings, Jeffrey L., et al. Evoke and Evoke+: Design of Two Large-scale, Double-blind, Placebo-controlled, Phase 3 Studies Evaluating Efficacy, Safety, and Tolerability of Semaglutide in Early-stage Symptomatic Alzheimer’s Disease. BMC.